Gender-based precision care for asthma
基于性别的哮喘精准护理
基本信息
- 批准号:10225221
- 负责人:
- 金额:$ 10.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-07 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:5q31Adrenal Cortex HormonesAdultAffectAgeAmericanAreaAsthmaAwardBiochemical PathwayBiologicalBody mass indexCandidate Disease GeneCharacteristicsChildChildhood AsthmaCiliaClinicClinicalClinical ResearchDataData SetDatabasesDevelopmentDevelopment PlansDoseDrug TargetingEducationEndocrinologyEnvironmentEpidemiologyEpithelial CellsEstradiolEuropeanExhibitsFemaleFoundationsGTP-Binding Protein alpha Subunits, GsGenderGenesGeneticGenetic RiskGenetic TranscriptionGenomicsGlucocorticoidsGlutamineGoalsGonadal Steroid HormonesHormonalIRF1 geneImmunityIncidenceInhalationInterferonsIsoleucineKnowledgeLaboratoriesLife Cycle StagesLinear RegressionsLongevityMenopauseMentorsMucociliary ClearanceNational Heart, Lung, and Blood InstituteNatural HistoryOutcomeParticipantPathogenesisPathway interactionsPatient CarePatientsPharmaceutical PreparationsPhysiciansPredispositionPrevalenceProductivityProgesteroneProteinsPubertyPulmonary Function Test/Forced Expiratory Volume 1ReportingResearchResearch InstituteResearch ProposalsRespiratory physiologyRiskRoleScientistSeveritiesSex DifferencesSingle Nucleotide PolymorphismSubgroupTestingTestosteroneTimeUbiquitinVariantVocational GuidanceWomanactivating transcription factor 1airway obstructionasthmaticbaseboyscareercareer developmentcohortepidemiology studyexperiencefemale sex hormonegender differencegenetic associationgenetic epidemiologygenetic variantgenome wide association studygenome-widegenomic locusgirlsimprovedinnovationmalemenmiddle agepatient orientedpersonalized careprogramsresponserisk variantsexsuccesstiotropium bromidewhole genome
项目摘要
ABSTRACT
Asthma affects boys more than girls, but gender-switch occurs after puberty and asthma is more common in
women than men. This research proposal investigates gender effect(s) on asthma severity. The long-term goal
of our studies is to identify sex related differences in genetic risks and biological pathways of severe asthma.
Our analyses of large databases reveal that severe asthma exhibits a bimodal peak in young boys and middle
age women [1, 2], which pointes to sex hormones in mechanisms of asthma severity [1]. Preliminary data of
sex hormone levels in participants with asthma from the Severe Asthma Research Program (SARP Iⅈ 2001-
2012) shows that men with both low progesterone and low testosterone and women with low testosterone and
high estradiol have the most severe airflow limitation. Additionally, our genome-wide association analyses of
single nucleotide polymorphism (SNP) x sex interaction and candidate gene analyses of European American
adults with asthma in SARP I & II shows sex-specific genetic associations with percent predicted FEV1, a
marker of severe asthma. Based on the findings, we hypothesize that risk of severe asthma is gender
dependent due to variation in levels of male and/or female sex hormones over the lifecourse and the
consequent interactions of sex hormones with asthma risk variants that result in a bimodal peak of severe
asthma in boys and women. In aim 1, we will assess SNP × sex interactions across the whole genome using
genome wide interaction study (GWIS). We will also use a candidate gene approach, which will determine SNP
x sex interactions in previously described asthma severity gene loci, such as lung function and immunity
pathway genes. In aim 2, we investigate the effect of variations in sex hormone levels on the risk for severe
asthma differentially in males and females. Equally important and parallel to the research plan, the career
development plan is constructed for didactic coursework, one-on-one education and career guidance from
strong mentors and collaborators expert in asthma, endocrinology, and analytical genetics. This research will
be performed in the laboratory of Dr. Erzurum, Lerner Research Institute (LRI), Cleveland Clinic, and will be
advised by experts in genomics and biochemical pathways unique to asthma. The LRI offers the ideal
intellectual and research environment for success. The proposed research is innovative and significant as it
may lay the groundwork for the care of patients with severe asthma in a personalized, gender specific way.
Altogether the award will provide the candidate the knowledge, hands-on experience, expertise and
productivity to develop into an independent physician-scientist focused on patient-centered mechanistic
research.
抽象的
哮喘对男孩的影响大于女孩,但性别转换发生在青春期后,哮喘在以下人群中更常见
该研究计划调查性别对哮喘严重程度的影响。
我们的研究目的是确定严重哮喘的遗传风险和生物学途径中与性别相关的差异。
我们对大型数据库的分析表明,严重哮喘在年轻男孩和中学中表现出双峰峰值
年龄女性 [1, 2],这表明性激素在哮喘严重程度的机制中 [1]。
严重哮喘研究计划 (SARP Iⅈ 2001-
2012)表明,孕酮和睾酮水平均较低的男性以及睾酮水平和睾酮水平均较低的女性
此外,我们的全基因组关联分析显示,高雌二醇具有最严重的气流限制。
欧洲裔美国人的单核苷酸多态性 (SNP) x 性别相互作用和候选基因分析
SARP I 和 II 中患有哮喘的成人显示,性别特异性遗传与预测的 FEV1 百分比存在关联,
根据研究结果,我们发现严重哮喘的风险是性别。
由于生命过程中男性和/或女性性激素水平的变化而依赖
性激素与哮喘风险变异的后续相互作用,导致严重哮喘的双峰峰值
在目标 1 中,我们将使用整个基因组评估 SNP × 性别相互作用。
我们还将使用候选基因方法来确定 SNP。
x 先前描述的哮喘严重程度基因位点中的性别相互作用,例如肺功能和免疫力
在目标 2 中,我们研究了性激素水平的变化对重症风险的影响。
哮喘在男性和女性中的差异与研究计划同等重要且平行。
发展计划是为教学课程、一对一教育和职业指导而制定的
这项研究将由哮喘、内分泌学和分析遗传学领域的专家提供强有力的指导和合作。
在克利夫兰诊所勒纳研究所 (LRI) Erzurum 博士的实验室中进行,并将
由哮喘特有的基因组学和生化途径专家提供的建议提供了理想的选择。
所提出的研究具有创新性和意义,因为它具有成功的智力和研究环境。
可能为以个性化、针对性别的方式治疗严重哮喘患者奠定基础。
总而言之,该奖项将为候选人提供知识、实践经验、专业知识和
生产力发展成为一名独立的医师科学家,专注于以患者为中心的机制
研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joe Zein其他文献
Joe Zein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joe Zein', 18)}}的其他基金
相似国自然基金
下丘脑室旁核促肾上腺皮质激素释放激素神经元调控奖赏偏好行为的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
孕期促肾上腺皮质激素释放激素(CRH)通过引起DNA甲基化发生程序化稳定改变长期影响婴幼儿神经行为发育
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:
INSM1在静默性促肾上腺皮质激素细胞腺瘤发生发展中的调控机制及潜在靶向治疗研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
促肾上腺皮质激素释放因子通过CRFR1-cAMP-SphK1通路介导肥大细胞脱颗粒参与胰腺癌痛外周敏化
- 批准号:82171232
- 批准年份:2021
- 资助金额:54 万元
- 项目类别:面上项目
催产素参与双相障碍发病机制的研究:聚焦于促肾上腺皮质激素释放激素与催产素之间的平衡紊乱
- 批准号:81971268
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Hormonal Contraceptives and Adolescent Brain Development
激素避孕药和青少年大脑发育
- 批准号:
10668018 - 财政年份:2023
- 资助金额:
$ 10.04万 - 项目类别:
Toward therapeutic targeting of liquid-liquid phase separation dynamics in skin
皮肤液-液相分离动力学的治疗靶向
- 批准号:
10679610 - 财政年份:2023
- 资助金额:
$ 10.04万 - 项目类别:
Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
大剂量口服孟鲁司特的剂量递增临床试验为哮喘急性发作儿童的未来随机对照试验提供信息
- 批准号:
10649012 - 财政年份:2023
- 资助金额:
$ 10.04万 - 项目类别:
Avoiding Cesarean-induced Obesity Through Hormone Rescue
通过激素拯救避免剖腹产引起的肥胖
- 批准号:
10628889 - 财政年份:2023
- 资助金额:
$ 10.04万 - 项目类别:
Harnessing single cell RNA sequencing and integrative bioinformatics to identify precision therapeutics for dermatomyositis
利用单细胞 RNA 测序和综合生物信息学确定皮肌炎的精准治疗方法
- 批准号:
10573015 - 财政年份:2023
- 资助金额:
$ 10.04万 - 项目类别: